OneMedNet Stock Tops $1 After $1.5 Million Insider Buying and Palantir Data Launch
OneMedNet Corporation jumped back over the $1 mark Friday, buoyed by insider filings revealing roughly $1.5 million in commitments to the clinical data outfit. The Nasdaq-listed name, aiming to convert its Palantir-supported platform into steady sales, was trading at $1.10. Volume cleared 11.6 million shares, according to market data.